Table 6.
. | Parameters | ||||||
---|---|---|---|---|---|---|---|
Treatment (T) | Electric Field Strength 1 | Pulses no | n | Protein Solubility (mg/g) | Protein Denaturation Enthalpy (ΔH, J/g) | ||
Myofibrillar | Sarcoplasmic | Total | |||||
Control | - | - | 5 | 180.3 ± 38.4 | 160.8 ab ± 7.62 | 341.1 ± 43.9 | 2.95 ± 0.35 |
T5 | Low | 450 | 5 | 150.5 ± 34.4 | 155.9 ab ± 8.94 | 306.4 ± 32.2 | 3.21 ± 0.29 |
T6 | High | 450 | 5 | 160.3 ± 46.7 | 150.1 b ± 10.3 | 310.4 ± 49.2 | 3.36 ± 0.74 |
T7 | Low | 600 | 5 | 143.1 ± 37.8 | 169.3 ab ± 15.2 | 312.4 ± 24.4 | 3.32 ± 0.25 |
T8 | High | 600 | 5 | 144.8 ± 24.3 | 175.9 a ± 20.4 | 304.7 ± 37.9 | 3.30 ± 0.16 |
p-Value | n.s. | * | n.s. | n.s. | |||
Planned contrast 2 | |||||||
Control | 5 | 180.3 ± 38.4 | 160.8 ± 7.62 | 341.1 ± 43.9 | 2.95 ± 0.35 | ||
Treated | 20 | 149.7 ± 34.4 | 162.8 ± 16.9 | 312.5 ± 34.2 | 3.30 ± 0.41 | ||
p-Value | n.s. | n.s. | n.s. | n.s. | |||
Low electric field strength | 10 | 146.8 ± 34.3 | 162.6 ± 13.7 | 309.4 ± 27.1 | 3.26 ± 0.25 | ||
High electric field strength | 10 | 152.5 ± 36.1 | 163.0 ± 20.4 | 315.5 ± 41.6 | 3.34 ± 0.53 | ||
p-Value | n.s. | n.s. | n.s. | n.s. | |||
450 pulses | 10 | 155.4 ± 34.4 | 153.0 ± 16.9 | 308.4 ± 34.2 | 3.30 ± 0.41 | ||
600 pulses | 10 | 143.9 ± 39.0 | 172.6 ± 9.56 | 316.5 ± 39.3 | 3.31 ± 0.56 | ||
p-Value | n.s | ** | n.s. | n.s. |
1 Low = 0.6 kV/cm; high = 1.2 kV/cm. 2 Control vs. treated (T5, T6, T7, T8); low electric field strength (T5, T7) vs. high electric field strength (T6, T8); 450 pulses (T5, T6) vs. 600 pulses (T7, T8).